Year |
Citation |
Score |
2023 |
Edwin RK, Acharya LP, Maity SK, Chakrabarti P, Tantia O, Joshi MB, Satyamoorthy K, Parsa KVL, Misra P. TGS1/PIMT knockdown reduces lipid accumulation in adipocytes, limits body weight gain and promotes insulin sensitivity in mice. Biochimica Et Biophysica Acta. Molecular Basis of Disease. 1870: 166896. PMID 37751782 DOI: 10.1016/j.bbadis.2023.166896 |
0.367 |
|
2023 |
Kapadia B, Behera S, Kumar ST, Shah T, Edwin RK, Babu PP, Chakrabarti P, Parsa KVL, Misra P. PIMT regulates hepatic gluconeogenesis in mice. Iscience. 26: 106120. PMID 36866247 DOI: 10.1016/j.isci.2023.106120 |
0.329 |
|
2020 |
Basu S, Barad M, Yadav D, Nandy A, Mukherjee B, Sarkar J, Chakrabarti P, Mukhopadhyay S, Biswas D. DBC1, p300, HDAC3, and Siah1 coordinately regulate ELL stability and function for expression of its target genes. Proceedings of the National Academy of Sciences of the United States of America. PMID 32152128 DOI: 10.1073/Pnas.1912375117 |
0.434 |
|
2020 |
Banerjee D, Chaudhuri RD, Niyogi S, Chowdhuri SR, Sarkar MP, Chatterjee R, Chakrabarti P, Sarkar S. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy. Journal of Molecular and Cellular Cardiology. PMID 31958467 DOI: 10.1016/J.Yjmcc.2020.01.004 |
0.393 |
|
2019 |
Sarkar J, Maity SK, Sen A, Nargis T, Ray D, Chakrabarti P. Impaired compensatory hyperinsulinemia among nonobese type 2 diabetes patients: a cross-sectional study. Therapeutic Advances in Endocrinology and Metabolism. 10: 2042018819889024. PMID 31832130 DOI: 10.1177/2042018819889024 |
0.321 |
|
2019 |
Sarkar J, Nargis T, Tantia O, Ghosh S, Chakrabarti P. Increased Plasma Dipeptidyl Peptidase-4 (DPP4) Activity Is an Obesity-Independent Parameter for Glycemic Deregulation in Type 2 Diabetes Patients. Frontiers in Endocrinology. 10: 505. PMID 31402899 DOI: 10.3389/Fendo.2019.00505 |
0.306 |
|
2019 |
Niyogi S, Ghosh M, Adak M, Chakrabarti P. PEDF promotes nuclear degradation of ATGL through COP1. Biochemical and Biophysical Research Communications. PMID 30926171 DOI: 10.1016/J.Bbrc.2019.03.111 |
0.38 |
|
2018 |
Adak M, Das D, Niyogi S, Nagalakshmi C, Ray D, Chakrabarti P. Inflammasome activation in Kupffer cells confers a protective response in nonalcoholic steatohepatitis through pigment epithelium-derived factor expression. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. fj201800190. PMID 29897812 DOI: 10.1096/Fj.201800190 |
0.335 |
|
2018 |
Palit S, Mukherjee S, Niyogi S, Banerjee A, Patra D, Chakraborty A, Chakrabarti S, Chakrabarti P, Dutta S. Quinoline-glycomimetic conjugates reducing lipogenesis and lipid accumulation in hepatocytes. Chembiochem : a European Journal of Chemical Biology. PMID 29897151 DOI: 10.1002/Cbic.201800271 |
0.335 |
|
2018 |
Khan W, Layden BT, Chakrabarti P. Inhibition of mTOR complexes protects cancer cells from glutamine starvation induced cell death by restoring Akt stability. Biochimica Et Biophysica Acta. PMID 29555211 DOI: 10.1016/J.Bbadis.2018.03.013 |
0.326 |
|
2018 |
Nargis T, Chakrabarti P. Significance of circulatory DPP4 activity in metabolic diseases. Iubmb Life. PMID 29331088 DOI: 10.1002/Iub.1709 |
0.364 |
|
2017 |
Nargis T, Kumar K, Ghosh AR, Sharma A, Rudra D, Sen D, Chakrabarti S, Mukhopadhyay S, Ganguly D, Chakrabarti P. KLK5 induces shedding of DPP4 from circulatory Th17 cells in type 2 diabetes. Molecular Metabolism. 6: 1529-1539. PMID 29107298 DOI: 10.1016/J.Molmet.2017.09.004 |
0.303 |
|
2017 |
Basu M, Sengupta I, Khan W, Srivastava DK, Chakrabarti P, Roy S, Das C. Dual histone reader ZMYND8 inhibits cancer cell invasion by positively regulating epithelial genes. The Biochemical Journal. PMID 28432260 DOI: 10.1042/Bcj20170223 |
0.354 |
|
2017 |
Basu M, Khan MW, Chakrabarti P, Das C. Chromatin reader ZMYND8 is a key target of all trans retinoic acid-mediated inhibition of cancer cell proliferation. Biochimica Et Biophysica Acta. 1860: 450-459. PMID 28232094 DOI: 10.1016/J.Bbagrm.2017.02.004 |
0.39 |
|
2016 |
Ghosh M, Niyogi S, Bhattacharyya M, Adak M, Nayak DK, Chakrabarti S, Chakrabarti P. Ubiquitin Ligase COP1 Controls Hepatic Fat Metabolism by Targeting ATGL for Degradation. Diabetes. PMID 27658392 DOI: 10.2337/Db16-0506 |
0.39 |
|
2016 |
Ghosh AR, Bhattacharya R, Bhattacharya S, Nargis T, Rahaman O, Duttagupta P, Raychaudhuri D, Chen Liu CS, Roy S, Ghosh P, Khanna S, Chaudhuri T, Tantia O, Haak S, Bandyopadhyay S, ... ... Chakrabarti P, et al. Adipose Recruitment and Activation of Plasmacytoid Dendritic Cells Fuel Metaflammation. Diabetes. PMID 27561727 DOI: 10.2337/Db16-0331 |
0.382 |
|
2016 |
Biswas D, Ghosh M, Kumar S, Chakrabarti P. PPARα-ATGL pathway improves muscle mitochondrial metabolism: implication in aging. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 27485820 DOI: 10.1096/Fj.201600571Rr |
0.314 |
|
2015 |
Khan M, Biswas D, Ghosh M, Mandloi S, Chakrabarti S, Chakrabarti P. mTORC2 controls cancer cell survival by modulating gluconeogenesis. Cell Death Discovery. 1: 15016-15016. PMID 27551450 DOI: 10.1038/Cddiscovery.2015.16 |
0.355 |
|
2015 |
Khan MW, Chakrabarti P. Gluconeogenesis combats cancer: opening new doors in cancer biology. Cell Death & Disease. 6: e1872. PMID 26335714 DOI: 10.1038/Cddis.2015.245 |
0.392 |
|
2015 |
Chakrabarti P, Kandror KV. The role of mTOR in lipid homeostasis and diabetes progression. Current Opinion in Endocrinology, Diabetes, and Obesity. 22: 340-6. PMID 26241026 DOI: 10.1097/Med.0000000000000187 |
0.599 |
|
2015 |
Singh M, Shin YK, Yang X, Zehr B, Chakrabarti P, Kandror KV. 4E-BPs Control Fat Storage by Regulating the Expression of Egr1 and ATGL. The Journal of Biological Chemistry. 290: 17331-8. PMID 25814662 DOI: 10.1074/Jbc.M114.631895 |
0.671 |
|
2014 |
Paul S, Banerjee N, Chatterjee A, Sau TJ, Das JK, Mishra PK, Chakrabarti P, Bandyopadhyay A, Giri AK. Arsenic-induced promoter hypomethylation and over-expression of ERCC2 reduces DNA repair capacity in humans by non-disjunction of the ERCC2-Cdk7 complex. Metallomics : Integrated Biometal Science. 6: 864-73. PMID 24473091 DOI: 10.1039/C3Mt00328K |
0.302 |
|
2013 |
Chakrabarti P, Kim JY, Singh M, Shin YK, Kim J, Kumbrink J, Wu Y, Lee MJ, Kirsch KH, Fried SK, Kandror KV. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway. Molecular and Cellular Biology. 33: 3659-66. PMID 23858058 DOI: 10.1128/Mcb.01584-12 |
0.674 |
|
2011 |
Karki S, Chakrabarti P, Huang G, Wang H, Farmer SR, Kandror KV. The multi-level action of fatty acids on adiponectin production by fat cells. Plos One. 6: e28146. PMID 22140527 DOI: 10.1371/Journal.Pone.0028146 |
0.729 |
|
2011 |
Chakrabarti P, English T, Karki S, Qiang L, Tao R, Kim J, Luo Z, Farmer SR, Kandror KV. SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. Journal of Lipid Research. 52: 1693-701. PMID 21743036 DOI: 10.1194/Jlr.M014647 |
0.722 |
|
2011 |
Chakrabarti P, Kandror KV. Adipose triglyceride lipase: a new target in the regulation of lipolysis by insulin. Current Diabetes Reviews. 7: 270-7. PMID 21644917 DOI: 10.2174/157339911796397866 |
0.664 |
|
2010 |
Chakrabarti P. Promoting adipose specificity: the adiponectin promoter. Endocrinology. 151: 2408-10. PMID 20489051 DOI: 10.1210/En.2010-0316 |
0.482 |
|
2010 |
Chakrabarti P, English T, Shi J, Smas CM, Kandror KV. Mammalian target of rapamycin complex 1 suppresses lipolysis, stimulates lipogenesis, and promotes fat storage. Diabetes. 59: 775-81. PMID 20068142 DOI: 10.2337/Db09-1602 |
0.629 |
|
2009 |
Chakrabarti P, Kandror KV. FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes. The Journal of Biological Chemistry. 284: 13296-300. PMID 19297333 DOI: 10.1074/Jbc.C800241200 |
0.684 |
|
2008 |
Chakrabarti P, Anno T, Manning BD, Luo Z, Kandror KV. The mammalian target of rapamycin complex 1 regulates leptin biosynthesis in adipocytes at the level of translation: the role of the 5'-untranslated region in the expression of leptin messenger ribonucleic acid. Molecular Endocrinology (Baltimore, Md.). 22: 2260-7. PMID 18653778 DOI: 10.1210/Me.2008-0148 |
0.676 |
|
Show low-probability matches. |